CLINICAL_TRIALS
trial_result
· 2015-12-17
Clinical Trial Update: Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients [Phase 2]
Summary
Phase 2 trial investigating maribavir for resistant or refractory CMV infections in transplant recipients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Cytomegalovirus (CMV) | Phase 2 | Status: COMPLETED | Results posted: 2015-12-17